MERCINELLI, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 49
AS - Asia 39
NA - Nord America 21
SA - Sud America 6
AF - Africa 1
Totale 116
Nazione #
RU - Federazione Russa 46
US - Stati Uniti d'America 20
CN - Cina 15
SG - Singapore 12
VN - Vietnam 5
BR - Brasile 4
JP - Giappone 3
IT - Italia 2
AR - Argentina 1
BD - Bangladesh 1
CO - Colombia 1
GB - Regno Unito 1
HK - Hong Kong 1
IN - India 1
IQ - Iraq 1
MX - Messico 1
SN - Senegal 1
Totale 116
Città #
Moscow 6
San Jose 4
Singapore 4
Brooklyn 2
Ho Chi Minh City 2
Los Angeles 2
Santa Clara 2
Arapongas 1
Beijing 1
Bologna 1
Cataguases 1
Council Bluffs 1
Da Nang 1
Dakar 1
Dallas 1
Denver 1
Erbil 1
Hong Kong 1
London 1
Medellín 1
Mexico City 1
Navsari 1
New York 1
Phú Thọ 1
Phủ Lý 1
Rockford 1
Salsipuedes 1
Sesto San Giovanni 1
São Paulo 1
Tokyo 1
Totale 45
Nome #
Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI 60
Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer 31
First results of NURE-Combo: A phase 2 study of neoadjuvant nivolumab (NIVO) and nab-paclitaxel (ABX) followed by postsurgical adjuvant NIVO in patients (pts) with muscle-invasive bladder cancer (MIBC) 12
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer 6
Comprehensive genomic profiling (CGP) of clinical T2-4N0M0 muscle-invasive bladder cancer (MIBC) treated with neoadjuvant pembrolizumab or cisplatinbased chemotherapy before radical cystectomy (RC) 4
The role of androgen response pathway in association with tumor biology and response to neoadjuvant immune-checkpoint inhibitors (ICI) in muscle-invasive urothelial bladder carcinoma (MIBC) 4
Utility of fluoro-deoxy-glucose positron emission tomography (FDG-PET) to predict a pelvic lymph node involvement (LNI) in patients (pts) with muscle-invasive bladder cancer (MIBC) enrolled in neoadjuvant therapy trials 3
Optimizing the Use of Next-Generation Sequencing Assays in Patients With Urothelial Carcinoma: Recommendations by the 2023 San Raffaele Retreat Panel 3
Myocarditis Following Pembrolizumab Plus Axitinib, and Belzutifan Plus Lenvatinib for Renal Cell Carcinoma: A Case Report 3
Distinct Gene Expression Patterns Identify Patients who Relapse After Neoadjuvant Pembrolizumab and Radical Cystectomy in the PURE-01 Study 2
Totale 128
Categoria #
all - tutte 227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 227


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026128 0 0 0 0 17 9 4 13 52 33 0 0
Totale 128